Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation-specific NPM1 immunohistochemistry is a sensitive method for detecting residual disease in mid- and postinduction bone marrows: comparison of NPM1 immunohistochemistry, NPM1 real-time polymerase chain reaction, and flow cytometric studies.

American journal of clinical pathology·2026
Same author

The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

The American journal of surgical pathology·2026
Same author

High-parameter flow cytometry for clinical laboratories-Worth it or not?

Cytometry. Part B, Clinical cytometry·2026
Same author

COMIP-001: A clinical 13-antibody, 12-color flow cytometry panel for optimized immunophenotyping of T/NK cells in human leukemia and lymphoma diagnostics.

Cytometry. Part B, Clinical cytometry·2026
Same author

Authors' Response to Letter from Khanolkar and Ahmed concerning our article "An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel" (Panakkal et al., 2025). Cytometry Part B: Clinical Cytometry. DOI: 10.1002/cyto.b.22246. PMID: 40657818.

Cytometry. Part B, Clinical cytometry·2025
Same author

International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories.

Cytometry. Part B, Clinical cytometry·2025

Related Experiment Video

Updated: Jun 21, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

T-prolymphocytic leukemia with three distinct immunophenotypic subsets.

Nana P Matsumoto1, Katelynn E Davis2, Nidhi Aggarwal2

  • 1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. matsumoton@upmc.edu.

Virchows Archiv : an International Journal of Pathology
|March 17, 2026
PubMed
Summary
This summary is machine-generated.

T-prolymphocytic leukemia (T-PLL) typically presents uniformly, but this rare cancer can show distinct abnormal T-cell subsets. TRBC1 flow cytometry analysis revealed intratumoral heterogeneity in one T-PLL patient.

Keywords:
Flow cytometryT-prolymphocytic leukemiaTRBC1

More Related Videos

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
08:58

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning

Published on: November 19, 2018

13.2K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.9K

Related Experiment Videos

Last Updated: Jun 21, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
08:58

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning

Published on: November 19, 2018

13.2K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.9K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • T-prolymphocytic leukemia (T-PLL) is a rare, aggressive mature T-cell neoplasm.
  • It is characterized by chromosome 14 rearrangements leading to TCL1 oncogene overexpression.
  • Neoplastic cells usually exhibit a mature T-cell immunophenotype (CD4+).

Purpose of the Study:

  • To describe a rare case of T-PLL with significant intratumoral heterogeneity.
  • To highlight the utility of TRBC1 analysis in flow cytometry for T-PLL diagnosis.

Main Methods:

  • Multiparametric flow cytometry analysis.
  • Utilized TRBC1 staining to delineate T-cell subsets.
  • Case report of a T-PLL patient.

Main Results:

  • Identified three distinct abnormal T-cell subsets in a single T-PLL case.
  • Demonstrated phenotypic heterogeneity not typically observed in T-PLL.
  • TRBC1 analysis proved valuable in distinguishing these subsets.

Conclusions:

  • T-PLL can exhibit striking intratumoral heterogeneity, challenging the notion of phenotypic uniformity.
  • TRBC1 flow cytometry is a useful tool for detailed diagnostic assessment and understanding T-PLL complexity.
  • This finding emphasizes the importance of comprehensive immunophenotyping in rare hematologic malignancies.